Abstract
Learning Objectives
- Describe the complex nature and current recommendations for antithrombotic therapy for non-valvular AF patients undergoing PCI
- Define the complications associated with TAT
- Summarize the latest data utilizing NOAC therapy in AF patients undergoing PCI
Citation
Byrne R, Hohnloser S, Nickenig G, Sendon JL and Zamarano JL, Radcliffe-CME, Feb 2018.